Medical - Care Facilities
Compare Stocks
3 / 10Stock Comparison
EHAB vs ADUS vs ENSG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
EHAB vs ADUS vs ENSG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $706M | $1.81B | $10.18B |
| Revenue (TTM) | $1.06B | $1.45B | $5.27B |
| Net Income (TTM) | $-3M | $100M | $363M |
| Gross Margin | 34.5% | 32.5% | 15.2% |
| Operating Margin | 7.2% | 9.8% | 8.5% |
| Forward P/E | 22.8x | 14.1x | 23.2x |
| Total Debt | $500M | $209M | $4.15B |
| Cash & Equiv. | $44M | $82M | $504M |
EHAB vs ADUS vs ENSG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 22 | May 26 | Return |
|---|---|---|---|
| Enhabit, Inc. (EHAB) | 100 | 60.0 | -40.0% |
| Addus HomeCare Corp… (ADUS) | 100 | 116.8 | +16.8% |
| The Ensign Group, I… (ENSG) | 100 | 237.2 | +137.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EHAB vs ADUS vs ENSG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EHAB is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.44, Low D/E 88.6%, current ratio 1.63x
- +68.0% vs ADUS's -13.4%
ADUS has the current edge in this matchup, primarily because of its strength in growth exposure and valuation efficiency.
- Rev growth 23.2%, EPS growth 23.2%, 3Y rev CAGR 14.4%
- PEG 0.70 vs ENSG's 1.68
- 23.2% revenue growth vs EHAB's 2.4%
ENSG is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 12 yrs, beta 0.42, yield 0.1%
- 7.5% 10Y total return vs ADUS's 399.9%
- Beta 0.42, yield 0.1%, current ratio 1.42x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.2% revenue growth vs EHAB's 2.4% | |
| Value | Lower P/E (14.1x vs 23.2x), PEG 0.70 vs 1.68 | |
| Quality / Margins | 6.9% margin vs EHAB's -0.3% | |
| Stability / Safety | Beta 0.42 vs ADUS's 0.58 | |
| Dividends | 0.1% yield; 12-year raise streak; the other 2 pay no meaningful dividend | |
| Momentum (1Y) | +68.0% vs ADUS's -13.4% | |
| Efficiency (ROA) | 7.0% ROA vs EHAB's -0.3%, ROIC 8.8% vs 4.5% |
EHAB vs ADUS vs ENSG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EHAB vs ADUS vs ENSG — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ENSG leads in 3 of 6 categories
EHAB leads 1 • ADUS leads 1 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ENSG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENSG is the larger business by revenue, generating $5.3B annually — 5.0x EHAB's $1.1B. ENSG is the more profitable business, keeping 6.9% of every revenue dollar as net income compared to EHAB's -0.3%. On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $1.4B | $5.3B |
| EBITDAEarnings before interest/tax | $98M | $159M | $558M |
| Net IncomeAfter-tax profit | -$3M | $100M | $363M |
| Free Cash FlowCash after capex | $81M | $137M | $406M |
| Gross MarginGross profit ÷ Revenue | +34.5% | +32.5% | +15.2% |
| Operating MarginEBIT ÷ Revenue | +7.2% | +9.8% | +8.5% |
| Net MarginNet income ÷ Revenue | -0.3% | +6.9% | +6.9% |
| FCF MarginFCF ÷ Revenue | +7.6% | +9.5% | +7.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.9% | +7.7% | +18.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.9% | +17.2% | +21.9% |
Valuation Metrics
EHAB leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 18.7x trailing earnings, ADUS trades at a 37% valuation discount to ENSG's 29.8x P/E. Adjusting for growth (PEG ratio), ADUS offers better value at 0.93x vs ENSG's 2.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $706M | $1.8B | $10.2B |
| Enterprise ValueMkt cap + debt − cash | $1.2B | $1.9B | $13.8B |
| Trailing P/EPrice ÷ TTM EPS | -152.10x | 18.67x | 29.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.84x | 14.12x | 23.19x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.93x | 2.16x |
| EV / EBITDAEnterprise value multiple | 13.47x | 12.52x | 25.71x |
| Price / SalesMarket cap ÷ Revenue | 0.67x | 1.28x | 2.01x |
| Price / BookPrice ÷ Book value/share | 1.24x | 1.65x | 4.59x |
| Price / FCFMarket cap ÷ FCF | 10.73x | 17.48x | 27.46x |
Profitability & Efficiency
ADUS leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ENSG delivers a 16.6% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-1 for EHAB. ADUS carries lower financial leverage with a 0.19x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x. On the Piotroski fundamental quality scale (0–9), ADUS scores 7/9 vs ENSG's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | -0.6% | +9.3% | +16.6% |
| ROA (TTM)Return on assets | -0.3% | +7.0% | +6.8% |
| ROICReturn on invested capital | +4.5% | +8.8% | +7.0% |
| ROCEReturn on capital employed | +6.0% | +10.9% | +10.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.89x | 0.19x | 1.86x |
| Net DebtTotal debt minus cash | $456M | $127M | $3.7B |
| Cash & Equiv.Liquid assets | $44M | $82M | $504M |
| Total DebtShort + long-term debt | $500M | $209M | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | 0.83x | 14.45x | 88.33x |
Total Returns (Dividends Reinvested)
ENSG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $5,512 for EHAB. Over the past 12 months, EHAB leads with a +68.0% total return vs ADUS's -13.4%. The 3-year compound annual growth rate (CAGR) favors ENSG at 23.6% vs EHAB's 0.7% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +51.6% | -8.7% | +0.3% |
| 1-Year ReturnPast 12 months | +68.0% | -13.4% | +27.5% |
| 3-Year ReturnCumulative with dividends | +2.1% | +16.3% | +88.9% |
| 5-Year ReturnCumulative with dividends | -44.9% | +0.0% | +103.2% |
| 10-Year ReturnCumulative with dividends | -44.9% | +399.9% | +752.0% |
| CAGR (3Y)Annualised 3-year return | +0.7% | +5.2% | +23.6% |
Risk & Volatility
Evenly matched — EHAB and ENSG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than ADUS's 0.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EHAB currently trades 96.9% from its 52-week high vs ADUS's 78.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.44x | 0.58x | 0.42x |
| 52-Week HighHighest price in past year | $14.22 | $124.44 | $218.00 |
| 52-Week LowLowest price in past year | $6.47 | $90.89 | $133.81 |
| % of 52W HighCurrent price vs 52-week peak | +96.9% | +78.2% | +80.0% |
| RSI (14)Momentum oscillator 0–100 | 58.6 | 49.3 | 23.3 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 236K | 358K |
Analyst Outlook
ENSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: EHAB as "Hold", ADUS as "Buy", ENSG as "Buy". Consensus price targets imply 32.3% upside for ADUS (target: $129) vs -1.8% for EHAB (target: $14). ENSG is the only dividend payer here at 0.14% yield — a key consideration for income-focused portfolios.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $13.53 | $128.67 | $222.33 |
| # AnalystsCovering analysts | 11 | 15 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.1% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 12 |
| Dividend / ShareAnnual DPS | — | — | $0.24 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.2% |
ENSG leads in 3 of 6 categories (Income & Cash Flow, Total Returns). EHAB leads in 1 (Valuation Metrics). 1 tied.
EHAB vs ADUS vs ENSG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EHAB or ADUS or ENSG a better buy right now?
For growth investors, Addus HomeCare Corporation (ADUS) is the stronger pick with 23.
2% revenue growth year-over-year, versus 2. 4% for Enhabit, Inc. (EHAB). Addus HomeCare Corporation (ADUS) offers the better valuation at 18. 7x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate Addus HomeCare Corporation (ADUS) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EHAB or ADUS or ENSG?
On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 18.
7x versus The Ensign Group, Inc. at 29. 8x. On forward P/E, Addus HomeCare Corporation is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Addus HomeCare Corporation wins at 0. 70x versus The Ensign Group, Inc. 's 1. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — EHAB or ADUS or ENSG?
Over the past 5 years, The Ensign Group, Inc.
(ENSG) delivered a total return of +103. 2%, compared to -44. 9% for Enhabit, Inc. (EHAB). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus EHAB's -44. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EHAB or ADUS or ENSG?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 42β versus Addus HomeCare Corporation's 0. 58β — meaning ADUS is approximately 36% more volatile than ENSG relative to the S&P 500. On balance sheet safety, Addus HomeCare Corporation (ADUS) carries a lower debt/equity ratio of 19% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EHAB or ADUS or ENSG?
By revenue growth (latest reported year), Addus HomeCare Corporation (ADUS) is pulling ahead at 23.
2% versus 2. 4% for Enhabit, Inc. (EHAB). On earnings-per-share growth, the picture is similar: Enhabit, Inc. grew EPS 97. 1% year-over-year, compared to 14. 1% for The Ensign Group, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EHAB or ADUS or ENSG?
The Ensign Group, Inc.
(ENSG) is the more profitable company, earning 6. 8% net margin versus -0. 4% for Enhabit, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADUS leads at 9. 7% versus 6. 0% for EHAB. At the gross margin level — before operating expenses — EHAB leads at 46. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EHAB or ADUS or ENSG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Addus HomeCare Corporation (ADUS) is the more undervalued stock at a PEG of 0. 70x versus The Ensign Group, Inc. 's 1. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Addus HomeCare Corporation (ADUS) trades at 14. 1x forward P/E versus 23. 2x for The Ensign Group, Inc. — 9. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ADUS: 32. 3% to $128. 67.
08Which pays a better dividend — EHAB or ADUS or ENSG?
In this comparison, ENSG (0.
1% yield) pays a dividend. EHAB, ADUS do not pay a meaningful dividend and should not be held primarily for income.
09Is EHAB or ADUS or ENSG better for a retirement portfolio?
For long-horizon retirement investors, The Ensign Group, Inc.
(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +752. 0% 10Y return). Both have compounded well over 10 years (ENSG: +752. 0%, EHAB: -44. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EHAB and ADUS and ENSG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EHAB is a small-cap quality compounder stock; ADUS is a small-cap high-growth stock; ENSG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.